Contact Us
Global Neurodiagnostics Market Report 2025

Neurodiagnostics Global Market Report 2025 – By Type (Diagnostic And Imaging Solutions, In-Vitro Diagnostics), By Technology (Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics), By Condition (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Stroke, Joint Health, Other Conditions), By End Use  (Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses) – Market Size, Trends, And Global Forecast 2025-2034

Neurodiagnostics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Neurodiagnostics Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Neurodiagnostics Market?

Neurodiagnostics refers to the medical field focused on diagnosing and monitoring disorders of the nervous system, including the brain, spinal cord, and peripheral nerves. It involves the use of advanced technologies and tests to assess neurological function, identify abnormalities, and aid in the diagnosis of conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.?

The main types of neurodiagnostic are diagnostic and imaging solutions and In-Vitro Diagnostics. Diagnostic and imaging solutions involve medical technologies and services designed to diagnose health conditions using various imaging techniques and diagnostic tools. Key technologies include neuroimaging, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine imaging (PET, SPECT), near-infrared spectroscopic imaging (NIRS), electroencephalography (EEG), magnetoencephalography (MEG), voxel-based morphometry (VBM), and neuroinformatics. These diagnostic tools are essential in the treatment of conditions such as epilepsy, alzheimer's disease, parkinson's disease, stroke, joint health issues, and others and are utilized in hospitals, clinics, diagnostic laboratories, imaging centers, and others.

Neurodiagnostics Market Size and growth rate 2025 to 2029: Graph

What Is The Neurodiagnostics Market Size 2025 And Growth Rate?

The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.17 billion in 2024 to $9.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rise in prevalence of neurological disorders, increase in adoption of advanced imaging technologies, growth in geriatric population, increase in awareness of early disease diagnosis, expanding healthcare infrastructure, and rise in investments in neuroscience research and development.

What Is The Neurodiagnostics Market Growth Forecast?

The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to $12.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for non-invasive diagnostic techniques, growing prevalence of neurological disorders, rising government investments in healthcare infrastructure, rising awareness and early detection initiatives, and expansion of personalized medicine approaches. Major trends in the forecast period include development of portable EEG devices, integration of AI for improved diagnostic accuracy, enhanced MRI technologies for brain imaging, adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and adoption of real-time data analytics for personalized treatment plans.

How Is The Neurodiagnostics Market Segmented?

The neurodiagnostics market covered in this report is segmented –

1) By Type: Diagnostic And Imaging Solutions, In-Vitro Diagnostics

2) By Technology: Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics

3) By Condition: Epilepsy, Alzheimer's Disease, Parkinson's Disease, Stroke, Joint Health, Other Conditions

4) By End Use : Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses

Subsegments:

1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems, CT (Computed Tomography) Scanners, EEG (Electroencephalogram) Systems, EMG (Electromyography) Systems, MEG (Magnetoencephalography) Systems, PET (Positron Emission Tomography) Scanners, SPECT (Single Photon Emission Computed Tomography) Scanners, Functional MRI (fMRI) Systems, Intracranial Pressure Monitors

2) By In-Vitro Diagnostics: Blood-Based Diagnostics, Cerebrospinal Fluid (Csf) Analysis, Genetic Testing And Biomarkers, Neurochemical Diagnostics, Point-Of-Care Neurodiagnostics, Diagnostic Kits For Neurodegenerative Disorders

What Is Driving The Neurodiagnostics Market? Rising Prevalence Of Neurological Disorders Driving Growth In The Market

The increasing prevalence of neurological disorders is expected to drive the growth of the neurodiagnostics market going forward. Neurological disorders are conditions that impact the brain, spinal cord, or nerves, leading to various cognitive, motor, and sensory impairments. The rise in neurological disorders is largely due to aging populations, environmental factors, lifestyle changes, genetics, and better diagnostic techniques. Neurodiagnostics are essential for accurately identifying, assessing, and monitoring neurological disorders, enabling precise diagnosis, informed treatment decisions, and effective management of conditions affecting the brain, spinal cord, and nerves. For instance, in April 2023, according to the National Library of Medicine, a US-based medical library for medical research information, it was reported that, in 2023, 6.7 million Americans are affected by Alzheimer's, and this number is expected to grow to 13.8 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the neurodiagnostics market.

Who Are The Major Players In The Global Neurodiagnostics Market?

Major companies operating in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., Intch Inc.

What Are The Key Trends Of The Global Neurodiagnostics Market? Advancements In AI-Driven Software For Enhanced Diagnostic Accuracy

Major companies operating in the neurodiagnostics market are focusing on technological advancements such as an advanced software algorithm to enhance diagnostic accuracy and improve patient outcomes. An advanced software algorithm refers to a sophisticated set of instructions that processes and analyzes data using techniques such as artificial intelligence (AI) or machine learning to enhance decision-making and diagnostics. For instance, in October 2023, Ceribell Inc., a US-based medical equipment manufacturing company, launched the ClarityPro AI algorithm, marking a significant advancement in diagnosing electrographic status epilepticus (ESE). This state-of-the-art software, integrated into the Ceribell EEG system, leverages machine learning to analyze EEG waveforms and deliver real-time alerts for suspected seizures. Notably, ClarityPro is the first acute care device to receive FDA clearance for standalone diagnosis. This innovative technology is designed to improve clinical decision-making by continuously monitoring brain activity, offering actionable insights, and enabling faster and more effective treatment responses.

What Are Latest Mergers And Acquisitions In The Neurodiagnostics Market? ArchiMed SAS Acquires Natus Medical To Expand Healthcare Innovation

In July 2022, ArchiMed SAS, a France-based investment company focused on healthcare industries, acquired Natus Medical Incorporated for $1.1 billion. The acquisition strengthens ArchiMed's position in neurodiagnostic devices and leverages Natus' expertise to drive innovation and growth. Natus Medical Incorporated is a US-based medical device company that specializes in medical devices for screening, diagnosing, and treating neurological disorders.

What Is The Regional Outlook For The Global Neurodiagnostics Market?

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurodiagnostics Market?

The neurodiagnostics market includes revenues earned by entities by providing services such as electroencephalography (EEG), positron emission tomography (PET), cerebrospinal fluid (CSF) analysis, and sleep apnea diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurodiagnostic market consists of sales of transcranial magnetic stimulation (TMS) devices, magnetoencephalography (MEG) systems, polysomnography (PSG) devices, and biosensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Neurodiagnostics Industry?

The neurodiagnostic market research report is one of a series of new reports from The Business Research Company that provides neurodiagnostic market statistics, including the neurodiagnostic industry's global market size, regional shares, competitors with a neurodiagnostic market share, detailed neurodiagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the neurodiagnostic industry. This neurodiagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Neurodiagnostics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 9.82 billion
Revenue Forecast In 2034 $12.79 billion
Growth Rate CAGR of 6.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The neurodiagnostics market covered in this report is segmented –
1) By Type: Diagnostic And Imaging Solutions, In-Vitro Diagnostics
2) By Technology: Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics
3) By Condition: Epilepsy, Alzheimer's Disease, Parkinson's Disease, Stroke, Joint Health, Other Conditions
4) By End Use : Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses Subsegments:
1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems, CT (Computed Tomography) Scanners, EEG (Electroencephalogram) Systems, EMG (Electromyography) Systems, MEG (Magnetoencephalography) Systems, PET (Positron Emission Tomography) Scanners, SPECT (Single Photon Emission Computed Tomography) Scanners, Functional MRI (fMRI) Systems, Intracranial Pressure Monitors
2) By In-Vitro Diagnostics: Blood-Based Diagnostics, Cerebrospinal Fluid (Csf) Analysis, Genetic Testing And Biomarkers, Neurochemical Diagnostics, Point-Of-Care Neurodiagnostics, Diagnostic Kits For Neurodegenerative Disorders
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., Intch Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Neurodiagnostics Market Characteristics

    3. Neurodiagnostics Market Trends And Strategies

    4. Neurodiagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Neurodiagnostics Growth Analysis And Strategic Analysis Framework

    5.1. Global Neurodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Neurodiagnostics Market Growth Rate Analysis

    5.4. Global Neurodiagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Neurodiagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Neurodiagnostics Total Addressable Market (TAM)

    6. Neurodiagnostics Market Segmentation

    6.1. Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Diagnostic And Imaging Solutions

    In-Vitro Diagnostics

    6.2. Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Neuroimaging Technologies

    Computed Tomography (CT)

    Magnetic Resonance Imaging (MRI)

    Nuclear Medicine Imaging (PET, SPECT)

    Near Infrared Spectroscopic Imaging (NIRS)

    Electro-Encephalography (EEG)

    Magneto-Encephalography (MEG)

    Voxel Based Morphometry (VBM)

    Neuroinformatics

    6.3. Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Epilepsy

    Alzheimer's Disease

    Parkinson's Disease

    Stroke

    Joint Health

    Other Conditions

    6.4. Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals And Clinics

    Diagnostic Laboratories

    Imaging Centers

    Other End Uses

    6.5. Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    MRI (Magnetic Resonance Imaging) Systems

    CT (Computed Tomography) Scanners

    EEG (Electroencephalogram) Systems

    EMG (Electromyography) Systems

    MEG (Magnetoencephalography) Systems

    PET (Positron Emission Tomography) Scanners

    SPECT (Single Photon Emission Computed Tomography) Scanners

    Functional MRI (fMRI) Systems

    Intracranial Pressure Monitors

    6.6. Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Blood-Based Diagnostics

    Cerebrospinal Fluid (Csf) Analysis

    Genetic Testing And Biomarkers

    Neurochemical Diagnostics

    Point-Of-Care Neurodiagnostics

    Diagnostic Kits For Neurodegenerative Disorders

    7. Neurodiagnostics Market Regional And Country Analysis

    7.1. Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Neurodiagnostics Market

    8.1. Asia-Pacific Neurodiagnostics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Neurodiagnostics Market

    9.1. China Neurodiagnostics Market Overview

    9.2. China Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Neurodiagnostics Market

    10.1. India Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Neurodiagnostics Market

    11.1. Japan Neurodiagnostics Market Overview

    11.2. Japan Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Neurodiagnostics Market

    12.1. Australia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Neurodiagnostics Market

    13.1. Indonesia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Neurodiagnostics Market

    14.1. South Korea Neurodiagnostics Market Overview

    14.2. South Korea Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Neurodiagnostics Market

    15.1. Western Europe Neurodiagnostics Market Overview

    15.2. Western Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Neurodiagnostics Market

    16.1. UK Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Neurodiagnostics Market

    17.1. Germany Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Neurodiagnostics Market

    18.1. France Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Neurodiagnostics Market

    19.1. Italy Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Neurodiagnostics Market

    20.1. Spain Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Neurodiagnostics Market

    21.1. Eastern Europe Neurodiagnostics Market Overview

    21.2. Eastern Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Neurodiagnostics Market

    22.1. Russia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Neurodiagnostics Market

    23.1. North America Neurodiagnostics Market Overview

    23.2. North America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Neurodiagnostics Market

    24.1. USA Neurodiagnostics Market Overview

    24.2. USA Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Neurodiagnostics Market

    25.1. Canada Neurodiagnostics Market Overview

    25.2. Canada Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Neurodiagnostics Market

    26.1. South America Neurodiagnostics Market Overview

    26.2. South America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Neurodiagnostics Market

    27.1. Brazil Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Neurodiagnostics Market

    28.1. Middle East Neurodiagnostics Market Overview

    28.2. Middle East Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Neurodiagnostics Market

    29.1. Africa Neurodiagnostics Market Overview

    29.2. Africa Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Neurodiagnostics Market Competitive Landscape And Company Profiles

    30.1. Neurodiagnostics Market Competitive Landscape

    30.2. Neurodiagnostics Market Company Profiles

    30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis

    31. Neurodiagnostics Market Other Major And Innovative Companies

    31.1. Ceribell Inc.

    31.2. CND Life Sciences Inc.

    31.3. Lifelines Neuro Inc.

    31.4. ANT Neuro B.V.

    31.5. Neurovative Diagnostics LLC

    31.6. Firefly Neuroscience Inc

    31.7. IntraNerve Neuroscience Inc

    31.8. NeuroDiagnostics Laboratories LLC

    31.9. Advanced Brain Monitoring Inc

    31.10. Spes Medica S.r.l.

    31.11. BioSignal Group Inc

    31.12. Combinostics Inc.

    31.13. Deymed Diagnostic LLC

    31.14. NeuLine Health Inc.

    31.15. Ridge Diagnostics Inc.

    32. Global Neurodiagnostics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Neurodiagnostics Market

    34. Recent Developments In The Neurodiagnostics Market

    35. Neurodiagnostics Market High Potential Countries, Segments and Strategies

    35.1 Neurodiagnostics Market In 2029 - Countries Offering Most New Opportunities

    35.2 Neurodiagnostics Market In 2029 - Segments Offering Most New Opportunities

    35.3 Neurodiagnostics Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Nihon Kohden Corporation Financial Performance
  • Table 78: Cephalon LLC Financial Performance
  • Table 79: Stratus Neuro LLC Financial Performance
  • Table 80: Cadwell Industries Inc. Financial Performance
  • Table 81: Compumedics Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Nihon Kohden Corporation Financial Performance
  • Figure 78: Cephalon LLC Financial Performance
  • Figure 79: Stratus Neuro LLC Financial Performance
  • Figure 80: Cadwell Industries Inc. Financial Performance
  • Figure 81: Compumedics Limited Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Neurodiagnostics market?

Neurodiagnostics refers to the medical field focused on diagnosing and monitoring disorders of the nervous system, including the brain, spinal cord, and peripheral nerves. It involves the use of advanced technologies and tests to assess neurological function, identify abnormalities, and aid in the diagnosis of conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.? For further insights on the Neurodiagnostics market, request a sample here

How will the Neurodiagnostics market drivers and restraints affect the market dynamics? What forces will shape the Neurodiagnostics industry going forward?

The Neurodiagnostics market major growth driver - Rising Prevalence Of Neurological Disorders Driving Growth In The Market. For further insights on the Neurodiagnostics market, request a sample here

What is the forecast market size or the forecast market value of the Neurodiagnostics market?

The Neurodiagnostics market size has grown strongly in recent years. The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.17 billion in 2024 to $9.82 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rise in prevalence of neurological disorders, increase in adoption of advanced imaging technologies, growth in geriatric population, increase in awareness of early disease diagnosis, expanding healthcare infrastructure, and rise in investments in neuroscience research and development. The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to $12.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for non-invasive diagnostic techniques, growing prevalence of neurological disorders, rising government investments in healthcare infrastructure, rising awareness and early detection initiatives, and expansion of personalized medicine approaches. Major trends in the forecast period include development of portable EEG devices, integration of AI for improved diagnostic accuracy, enhanced MRI technologies for brain imaging, adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and adoption of real-time data analytics for personalized treatment plans. For further insights on the Neurodiagnostics market, request a sample here

How is the Neurodiagnostics market segmented?

The neurodiagnostics market covered in this report is segmented –
1) By Type: Diagnostic And Imaging Solutions, In-Vitro Diagnostics
2) By Technology: Neuroimaging Technologies, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging (PET, SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electro-Encephalography (EEG), Magneto-Encephalography (MEG), Voxel Based Morphometry (VBM), Neuroinformatics
3) By Condition: Epilepsy, Alzheimer's Disease, Parkinson's Disease, Stroke, Joint Health, Other Conditions
4) By End Use : Hospitals And Clinics, Diagnostic Laboratories, Imaging Centers, Other End Uses Subsegments:
1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems, CT (Computed Tomography) Scanners, EEG (Electroencephalogram) Systems, EMG (Electromyography) Systems, MEG (Magnetoencephalography) Systems, PET (Positron Emission Tomography) Scanners, SPECT (Single Photon Emission Computed Tomography) Scanners, Functional MRI (fMRI) Systems, Intracranial Pressure Monitors
2) By In-Vitro Diagnostics: Blood-Based Diagnostics, Cerebrospinal Fluid (Csf) Analysis, Genetic Testing And Biomarkers, Neurochemical Diagnostics, Point-Of-Care Neurodiagnostics, Diagnostic Kits For Neurodegenerative Disorders For further insights on the Neurodiagnostics market,
request a sample here

Which region has the largest share of the Neurodiagnostics market? What are the other regions covered in the report?

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Neurodiagnostics market, request a sample here.

Who are the major players in the Neurodiagnostics market?

Major companies operating in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., Intch Inc. . For further insights on the Neurodiagnostics market, request a sample here.

What are the key trends in the Neurodiagnostics market?

Major trends in the Neurodiagnostics market include Advancements In AI-Driven Software For Enhanced Diagnostic Accuracy. For further insights on the Neurodiagnostics market, request a sample here.

What are the major opportunities in the Neurodiagnostics market? What are the strategies for the Neurodiagnostics market?

For detailed insights on the major opportunities and strategies in the Neurodiagnostics market, request a sample here.

How does the Neurodiagnostics market relate to the overall economy and other similar markets?

For detailed insights on Neurodiagnostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Neurodiagnostics industry?

For detailed insights on the mergers and acquisitions in the Neurodiagnostics industry, request a sample here.

What are the key dynamics influencing the Neurodiagnostics market growth? SWOT analysis of the Neurodiagnostics market.

For detailed insights on the key dynamics influencing the Neurodiagnostics market growth and SWOT analysis of the Neurodiagnostics industry, request a sample here.